RSS

Chinese Food and Drug Administration (CFDA)

Partner of STA Pharmaceutical, Ascletis, has been granted approval by the Chinese Food and Drug Administration (CFDA) for its Category 1 new drug, Ganovo (also known as Danoprevir or ASC08) to treat viral hepatitis C. Read more

News

Horizon Discovery Group has entered into a partnership with a life sciences company focused on accelerating the standardisation of diagnostic testing in China, Genewell Biotechnology. Read more

News

STA Pharmaceutical has reported rapid growth in companies intending to market their products in China using it as a partner following the CFDA announcement of the Market Authorization Holder (MAH) pilot programme last year Read more

Analysis

Swiss pharmaceutical group, Helsinn, has opened an office in Shanghai, China, as part of the group’s commitment to the region — Helsinn Pharmaceuticals (Beijing). Read more

News